Order Article Reprints

Bai Y, An C, Zhang X, Li K, Cheng F, Cui B, Song Z, Liu D, Zhang J, He Q, et al. A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine. Viruses. 2023; 15(5):1099. https://doi.org/10.3390/v15051099

Bai, Yu, Chaoqiang An, Xuanxuan Zhang, Kelei Li, Feiran Cheng, Bopei Cui, Ziyang Song, Dong Liu, Jialu Zhang, Qian He, and et al. 2023. "A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine" Viruses 15, no. 5: 1099. https://doi.org/10.3390/v15051099

Bai, Y., An, C., Zhang, X., Li, K., Cheng, F., Cui, B., Song, Z., Liu, D., Zhang, J., He, Q., Liu, J., Mao, Q., & Liang, Z. (2023). A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine. Viruses, 15(5), 1099. https://doi.org/10.3390/v15051099